The therapeutic efficacy of TIP1 was evaluated in MRL/lpr mouse, a well-known model of SLE characterized with high levels of circulating antibodies and inflammatory cytokines that develop an autoimmune disease similar to human SLE [22]. This evidence concerns the gene TAX1BP3 and autoimmune disease.